In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4819-4825

  Himmelrich, Hayo ^a   Launois, Pascal ^a   Maillard, Ivan ^a   Biedermann, Tilo ^b   Tacchini Cottier, Fabienne ^a   Locksley, Richard M ^c   Röcken, Martin ^b   Louis, Jacques A ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CELL MATURATION; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; HELPER CELL; IMMUNE RESPONSE; LEISHMANIA MAJOR; LYMPH NODE CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034193027     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4819     Document Type: Article

References (43)

1. Locksley, R. M., F. P. Heinzel, M. D. Sadick, B. J. Holaday, and K. D. Gardner. 1987. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T cell subsets. Ann. Inst. Pasteur/Immunol. 138:744.
2. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
3. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
4. + T cells. J. Immunol. 154:5071.
5. + T cells to enhance priming for interferon-γ production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.
6. Hsieh, C. S., A. B. Heimberger, J. S. Gold, A. O'Garra, and K. M. Murphy. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβ T-cell-receptor transgenic system. Proc. Natl. Acad. Sci. USA 89: 6065.
7. Le Gros, G., S. Z. Ben-Sasson, R. A. Seder, F. D. Finkelman, and W. E. Paul, 1990. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J. Exp. Med. 172:921.
8. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091.
9. Heinzel, F. P., R. M. Rerko, F. Ahmed, and E. Pearlman. 1995. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 155:730.
10. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553.
11. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182.
12. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: evidence for a T cell-dependent, interferon-γ independent mechanism. J. Exp. Med. 171:115.
13. -. Eur. J. Immunol. 25:3298.
14. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z. E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563.
15. + T cells in BALB/c mice infected with Leishmania major instructsTh2 cell development and susceptibility to infection. Immunity 6:541.
16. Maillard, I., K. Erny, H. Acha-Orbea, and H. Diggelmann. 1996. A Vβ4-specific superantigen encoded by a new exogenous mouse mammary tumor virus. Eur. J. Jmmunol. 26:1000.
17. Julia, V., M. Rassoulzadegan, and N. Glaichenhaus. 1996. Resistance to Leishmania major induced by tolerance to a single antigen. Science 274:421.
18. Racke, M. K., A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, and M. Rocken. 1994. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1961.
19. Röcken, M., J. Urban, and E. M. Shevach. 1994. Antigen-specific activation, tolerization, and reactivation of the interleukin-4 pathway in vivo. J. Exp. Med. 179:1885.
20. Noben-Trauth, N., P. Kropf, and I. Muller. 1996. Susceptibility to Leishmania major infection in IL-4 deficient mice. Science 271:912.
21. Held, W., A. N. Shakhov, G. Waanders, L. Scarpellino, R. Luethy, J. P. Kraehenbuhl, H. R. MacDonald, and H. Acha-Orbea. 1992. An exogenous mouse mammary tumor virus with properties of Mls-1a (mtv-7). J. Exp. Med. 175:1623.
22. Louis, J. A., E. Moedder, R. Behin, and H. D. Engers. 1979. Recognition of protozoan parasite antigens by murine T lymphocytes. Eur. J. Immunol. 9:841.
23. Levine, A. D., S. H. Rangwala, N. A. Horn, M. A. Peel, B. K. Matthews, R. M. Leimgruber, J. A. Manning, B. F. Bishop, and P. O. Olins. 1995. High level expression and refolding of mouse interleukin 4 synthesized in Escherichia coli. J. Biol. Chem. 270:7445.
24. Favre, N., and P. Erb. 1993. Use of the CTL44 cell line, a derivate of CTL/L cells, to identify and quantify mouse interleukin-4 by bioassay. J. Immunol. Methods 164:213.
25. Muller, I., T. Pedrazzini, J. P. Farrell, and J. Louis. 1989. T-cell responses and immunity to experimental infection with Leishmania major. Annu. Rev. Immunol. 7:561.
26. Launois, P., K. Swihart, G. Milon, and J. A. Louis. 1997. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J. Immunol. 158:3317.
27. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165:37.
28. + T cells resulting in a state of unresponsiveness to IL-12. J. Immunol. 161:6156.
29. Chua, A. O., V. L. Wilkinson, D. H. Presky, and U. Gubler. 1995. Cloning and characterisation of a mouse IL-12 receptor-β component. J. Immunol. 155:4286.
30. Presky, D. H., H. Yang, L. J. Minetti, A. O. Chu, N. Nabavi, C.-Y. Wu, M. Gately, and U. Gübler. 1996. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93:14002.
31. Slade, S. J., and J. Langhorne. 1989. Production of interferon-γ during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 179:353.
32. Titus, R. G., M. Marchand, T. Boon, and J. A. Louis. 1985. A limiting dilution assay for quantifying Leishmania major in tissue of infected mice. Parasite Immunol. 7:545.
33. + T cells. J. Immunol. 139:1303.
34. Titus, R. G., R. Ceredig, J. C. Cerottini, and J. A. Louis. 1985. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J. Immunol. 135:2108.
35. Pingel, S., P. Launois, D. J. Fowell, C. W. Turck, S. Southwood, A. Sette, N. Glaichenhaus, J. A. Louis, and R. M. Locksley. 1999. Altered ligands reveal limited plasticity in the T cell response to a pathogenic epitope. J. Exp. Med. 189:1111.
36. Reiner, S. L., Z.-E. Wang, F. Hatam, P. Scott, and R. M. Locksley. 1993. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science 259:1457.
37. Jones, D., M. M. Elloso, L. Showe, D. Williams, G. Trinchieri, and P. Scott. 1998. Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major. Infect. Immun. 66:3818.
38. Szabo, S. J., A. S. Dighe, U. Gübler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper (Th1) and Th2 cells. J. Exp. Med. 185:817.
39. Guler, M. L., J. D. Gorham, C. S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984.
40. Kopf, M., F. Brombacher, G. Kölher, G. Kienzle, K.-H. Widmann, K. Lefrang, C. Humborg, B. Ledermann, and W. Solbach. 1996. IL-4 deficient BALB/c mice resist infection with Leishmania major. J. Exp. Med. 184:1127.
41. Noben-Trauth, N., W. E. Paul, and D. L. Sacks. 1999. IL-4-and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 162:6132.
42. Mohrs, M., B. Ledermann, G. Kohler, A. Dorfmuller, A. Gessner, and F. Brombacher. 1999. Differences between IL-4-and IL-4 receptor α-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J. Immunol. 162:7302.
43. Kropf, P., R. Etges, L. Schopf, C. Chung, J. Sypek, and I. Muller. 1997. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4. J. Immunol. 159:3434.